Dr Michelle Tempest and Paul Fegan researched on Acquired Brain Injury (ABI).
Candesic is a leading strategy consultancy
head-quartered in London, serving private operators, investors, and public sector organisations.
A new era for the Electronic Patient Record
_**Michelle Tempest**_ look at doctors attitudes towards IT and explore if the holy grail of connectivity and personalised health can finally come to fruition.
HealthInvestor Power50 awards
Congratulations to **Dr Leonid Shapiro** , managing partne **_Candesic_** , on being nominated for [HealthInvestor](https://www.linkedin.com/company/healthinvestor/) _Power50 awards_ as a sector specialist. Power50 celebrate the most effective, inspiring and influential leaders across the health and social care market. Congratulations to all the nominees and see you at the awards!
Gynaecological health startup Daye fund-raising
U.K.-based gynaecological health startup Daye, which is known for having invented the CBD tampon that is now used by over 60,000 women in the U.K., has completed a $11.5 million funding round. Candesic's Dr Michelle Tempest has also invested in this latest successful Series A funding round.
© Candesic 2022